Lipids and secondary prevention of ischaemic heart disease - Lipid lowering treatment is now indicated for patients with ''normal'' cholesterol concentrations

被引：0
|
作者：
Byrne, CD
Wild, SH
机构：
[1] UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT MED, CAMBRIDGE CB2 2QR, ENGLAND
[2] UNIV LONDON LONDON SCH HYG & TROP MED, EPIDEMIOL UNIT, LONDON WC1E 7HT, ENGLAND
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1996年 / 313卷 / 7068期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1273 / 1274
页数：2
相关论文
共 50 条
  • [21] Lipid-lowering and secondary prevention of cardiovascular disease in vascular surgical in-patients
    Froehlich, JB
    Cote, M
    Singh, MJ
    Nelson, PR
    Rohrer, MJ
    Cutler, BS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 252A - 252A
  • [22] The use of lipid-lowering drugs across ethnic groups in the secondary prevention of ischaemic heart disease: analysis of cross-sectional surveys in England
    Gill, PS
    Quirke, TP
    Mant, JW
    Allan, TF
    BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (503): : 442 - 443
  • [23] Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe:: findings from EUROASPIRE study
    Vanuzzo, D
    Pilotto, L
    Ambrosio, GB
    Pyörälä, K
    Lehto, S
    De Bacquer, D
    De Backer, G
    Wood, D
    ATHEROSCLEROSIS, 2000, 153 (02) : 505 - 517
  • [24] Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
    Glasziou, PP
    Eckermann, SD
    Mulray, SE
    Simes, RJ
    Martin, AJ
    Kirby, AC
    Hall, JP
    Caleo, S
    White, HD
    Tonkin, AM
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (08) : 428 - 434
  • [25] Prevention and treatment of ischaemic heart disease are both important in patients with chronic kidney disease
    Drugs & Therapy Perspectives, 2009, 25 (6) : 19 - 21
  • [26] The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care
    Hippisley-Cox, J
    Pringle, M
    BRITISH JOURNAL OF GENERAL PRACTICE, 2000, 50 (458): : 699 - 705
  • [27] Lipid lowering therapy as an important adjunct to stroke prevention in coronary heart disease patients
    Rosenson, RS
    DRUGS OF TODAY, 2001, 37 (11) : 731 - 738
  • [28] Cholesterol management in patients with heart disease - Emphasizing secondary prevention to increase longevity
    Grundy, SM
    POSTGRADUATE MEDICINE, 1997, 102 (02) : 81 - +
  • [29] Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
    Steffens, Daniel
    Bramlage, Peter
    Mueller, Julia
    Dorn, Cornelia
    Paar, W. Dieter
    Scheeff, Celine
    Kasner, Mario
    Rauch-Kroehnert, U.
    OPEN HEART, 2021, 8 (01):
  • [30] Cholesterol management in high-risk patients without heart disease - When is lipid-lowering medication warranted for primary prevention?
    Grundy, SM
    POSTGRADUATE MEDICINE, 1998, 104 (05) : 117 - +
12345